BSECompany Update3d ago · 5 Aug 2026, 04:06 pm
PFA
Biogen Pharmachem Industries Ltd · 531752
✦ AI SummaryRegulatory
Biogen Pharmachem Industries Ltd has informed that it does not have any unused funds from past public issues or placements, as per SEBI's Regulation 32(1) of the Listing Obligation and Disclosure Requirements.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Biogen Pharmachem Industries Ltd - 531752 - Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
Attachments (1)
📄pdf
Download →
819c33ee-cb05-4ecc-bb2f-46faa840ce0a.pdf
View document text
BIOGEN
PHARMACHEM INDUSTRIES LIMITED
CIN NO: L51100GJ1995PLC026702 (Formerly Known as SUN TECHNO OVERSEAS LIMITED)
Date.:05.08.2026
Department of Corporate Services
BSE Limited,
Phiroze Jeejeebhoy Towers,
Dalal Street,
Mumbai - 400 001
Scrip Code: 531752 Security ID: BIOGEN
Dear Sir / Madam,
Sub: Disclosure under Regulation 32(1) of SEBI (listing Obligation and Disclosure Requirements) Regulations, 2015
Pursuant to SEBI Circular - CIR/CFD/CMD1/162/2019 dated 24th December, 2019 regarding statement on Deviation
or variation for proceeds of public issue/Rights Issue/preferential issue, Qualified institutional placement (QIP) etc.,
read with Regulation 32(1) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we would
like to inform that:
The Company does not have any funds remaining unutilised as on 30th June 2026, or as on date, out of the
proceeds of public issue/Rights Issue/preferential issue, qualified institutional placement (QIP) etc., if any
undertaken by it at anytime in the past.
In view of the aforesaid, no information is being provided by way of Annexure-A pursuant to the said Regulation /
Circular.
This is for your information and records.
Thanking You.
Yours Faithfully,
FOR, BIOGEN PHARMACHEM INDUSTRIES LIMITED
KELASH BUNKAR
WHOLETIME DIRECTOR
Registered Office Address: Shop No. 8, First Floor, Makers – 1 Building, Jawahar Road, Rajkot-360001
E mail biogenpharmachem@gmail.com